A Phase 1/1b Multicenter Study to Evaluate the Humanized Anti-CD 73 Antibody, CP-I006, As A Single Agent, In Combination With CPI-444, And In Combination With Pembrolizumab In Adult Subjects With Advanced Cancers
- Markman, Ben (Primary Chief Investigator (PCI))
- Body, Amy (Primary Chief Investigator (PCI))
Project: Research